Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefprozil Granules

Approval Number

国药准字H20080792

Company广州白云山医药集团股份有限公司白云山制药总厂

Registration Date

November 15, 2022

Drug Information

Generic Name

头孢丙烯颗粒

Brand Name

琥同

Dosage Form

颗粒剂

Strength

以C18H19N3O5S计0.25g

Drug Type

化学药品

Registration Date

November 15, 2022

Company Information

Applicant Company

Company Name广州白云山医药集团股份有限公司白云山制药总厂

Company Address

广州市白云区同和街云祥路88号

Manufacturing Company

Company Name广州白云山医药集团股份有限公司白云山制药总厂

Company Address

广州市白云区同和街云祥路88号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy